Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Decontamination by glycosylation based wipes

Cel

The increasing cross-border and cross-continental movement of people, goods and food, together with the global terrorism threat, have enormous potential to affect the emergence and spread of infectious diseases, including those caused by biothreat agents. Filling the need and gap in the marker for highly-portable, broadly-specific decontamination methods, Aquila BioScience has developed a novel Glyco-DeCon system. At the development stage the unique combination of sugars capturing biothreat agents was identified by using a novel microarray technology. In the Glyco-DeCon wipe, the sugars are chemically attached to the surface of a pre-treated, self-contained cellulose-based material. This approach targets natural binding sites of the biothreat agents and offers a non-toxic alternative to the harsh chemical decontamination methods. The Glyco-DeCon wipe is the safest method for biological decontamination described so far and can be used on human skin as well as the delicate surfaces of the mucosal epithelia or the human eye. Moreover, the product uses natural compounds like cotton and purified proteins reducing the environmental burden of toxic chemical approaches. The Glyco-DeCon kit is intended to become part of all first responder kits.

The Glyco-DeCon wipes have already been tested in Defence accredited labs and confirmed to be effective against persistent biothreat agents, including anthrax cells and spores. Over the next six months Aquila BioScience is intending to perform field testing for the prototype developed with support of Irish Defence Forces and will discuss the most suitable formats with the end users. Moreover, a patent application is being submitted for protecting the invented technology. The team will look into business and production feasibility to indicate the best distribution partner and to introduce the product into the market within the following year. The findings will be summarized in Feasibility Report and elaborated Business Plan.

Zaproszenie do składania wniosków

H2020-SMEInst-2016-2017

Zobacz inne projekty w ramach tego zaproszenia

Szczegółowe działanie

H2020-SMEINST-1-2016-2017

Koordynator

AQUILA BIOSCIENCE LIMITED
Wkład UE netto
€ 50 000,00
Adres
BALLINAHALLA
Moycullen Galway
Irlandia

Zobacz na mapie

MŚP

Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.

Tak
Region
Ireland Northern and Western West
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Linki
Koszt całkowity
€ 71 429,00